NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

組織診斷的全球市場:各產品,各技術,各應用領域,各終端用戶的預測(到2025年)- COVID-19累積的影響

Tissue Diagnostic Market Research Report by Product, by Technology, by Application, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1002756
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
組織診斷的全球市場:各產品,各技術,各應用領域,各終端用戶的預測(到2025年)- COVID-19累積的影響 Tissue Diagnostic Market Research Report by Product, by Technology, by Application, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

全球組織診斷的市場規模預測將從2020年的47億2,118萬美元,擴大到2025年末的65億3,964萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供全球組織診斷市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,產品·技術·應用·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 各終端用戶市場展望
  • 各產品市場展望
  • 各技術市場展望
  • 各應用領域市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各產品市場

  • 配件
  • 器具

第7章 各技術市場

  • 數位病理和工作流程
  • 免疫組織化學
  • 原位雜交
  • 特殊染色

第8章 各應用領域市場

  • 乳癌
  • 胃癌
  • 淋巴瘤
  • 非小細胞肺癌
  • 前列腺癌症

第9章 各終端用戶市場

  • 受託調查機關(CRO)
  • 醫院
  • 藥事關係團體
  • 研究

第10章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第14章 企業簡介

  • Abbott Laboratories Inc
  • ABCAM PLC
  • Agilent Technologies Inc
  • Amos Scientific PTY Ltd
  • Becton Dickinson & Company
  • Bio SB
  • Bio-Rad Laboratories Inc
  • Biogenex Laboratories Inc
  • bioMerieux Inc.
  • Cell Signalling Technology, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Histoline Laboratories
  • Johnson & Johnson
  • Merck KGaA
  • Pfizer Inc
  • QIAGEN N.V.
  • Sakura Finetek Japan Co.,Ltd.
  • Siemens Healthineers AG
  • Slee Medical GMBH
  • Thermo Fisher Scientific Inc

第15章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-03142C0401D6

The Global Tissue Diagnostic Market size was estimated at USD 4,721.18 Million in 2020 and expected to reach USD 5,062.69 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.57% to reach USD 7,315.48 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Tissue Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Tissue Diagnostic Market was studied across Accessories and Instruments.

Based on Technology, the Tissue Diagnostic Market was studied across Digital Pathology and Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.

Based on Application , the Tissue Diagnostic Market was studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.

Based on End-User, the Tissue Diagnostic Market was studied across Contract Research Organization (CRO), Hospitals, Pharmaceutical Organizations, and Research Laboratories.

Based on Geography, the Tissue Diagnostic Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tissue Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tissue Diagnostic Market, including Abbott Laboratories Inc, ABCAM PLC, Agilent Technologies Inc, Amos Scientific PTY Ltd, Becton Dickinson & Company, Bio SB, Bio-Rad Laboratories Inc, Biogenex Laboratories Inc, bioMerieux Inc., Cell Signalling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Histoline Laboratories, Johnson & Johnson, Merck KGaA, Pfizer Inc, QIAGEN N.V., Sakura Finetek Japan Co.,Ltd., Siemens Healthineers AG, Slee Medical GMBH, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Tissue Diagnostic Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Diagnostic Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Diagnostic Market?
  • 4. What is the competitive strategic window for opportunities in the Global Tissue Diagnostic Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Tissue Diagnostic Market?
  • 6. What is the market share of the leading vendors in the Global Tissue Diagnostic Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Tissue Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-User Outlook
  • 3.4. Product Outlook
  • 3.5. Technology Outlook
  • 3.6. Application Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cancer
      • 5.1.1.2. Growing use of personalized medicine
      • 5.1.1.3. Inception of automated tissue diagnostics to enhance assay performance and minimize the number of pathologists
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation in diagnostic testing for highly efficient testing
      • 5.1.3.2. Government initiatives to increase awareness regarding effective and early cancer diagnosis
      • 5.1.3.3. Rising investments in research and development of new technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework for approval of devices
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Tissue Diagnostic Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Instruments

7. Tissue Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital Pathology and Workflow
  • 7.3. Immunohistochemistry
  • 7.4. In Situ Hybridization
  • 7.5. Special Staining

8. Tissue Diagnostic Market, by Application

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Gastric Cancer
  • 8.4. Lymphoma
  • 8.5. Non Small Cell Lung Cancer
  • 8.6. Prostate Cancer

9. Tissue Diagnostic Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract Research Organization (CRO)
  • 9.3. Hospitals
  • 9.4. Pharmaceutical Organizations
  • 9.5. Research Laboratories

10. Americas Tissue Diagnostic Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Tissue Diagnostic Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Tissue Diagnostic Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories Inc
  • 14.2. ABCAM PLC
  • 14.3. Agilent Technologies Inc
  • 14.4. Amos Scientific PTY Ltd
  • 14.5. Becton Dickinson & Company
  • 14.6. Bio SB
  • 14.7. Bio-Rad Laboratories Inc
  • 14.8. Biogenex Laboratories Inc
  • 14.9. bioMerieux Inc.
  • 14.10. Cell Signalling Technology, Inc.
  • 14.11. Danaher Corporation
  • 14.12. F. Hoffmann-La Roche Ltd
  • 14.13. Histoline Laboratories
  • 14.14. Johnson & Johnson
  • 14.15. Merck KGaA
  • 14.16. Pfizer Inc
  • 14.17. QIAGEN N.V.
  • 14.18. Sakura Finetek Japan Co.,Ltd.
  • 14.19. Siemens Healthineers AG
  • 14.20. Slee Medical GMBH
  • 14.21. Thermo Fisher Scientific Inc

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2020 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL TISSUE DIAGNOSTIC MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL TISSUE DIAGNOSTIC MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 12. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 19. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2020 VS 2026 (%)
  • FIGURE 28. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2020 VS 2026 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2026
  • FIGURE 30. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 41. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2026
  • FIGURE 43. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), 2018-2026 (USD MILLION)
  • FIGURE 44. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 46. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, 2018-2026 (USD MILLION)
  • FIGURE 48. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 50. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 52. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 54. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. CANADA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. CALIFORNIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. FLORIDA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. ILLINOIS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. NEW YORK TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. OHIO TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. PENNSYLVANIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. TEXAS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 67. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 69. CHINA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. INDIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 78. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 79. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 80. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. ITALY TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. QATAR TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 87. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 88. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. GLOBAL TISSUE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX
  • FIGURE 92. GLOBAL TISSUE DIAGNOSTIC MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 93. GLOBAL TISSUE DIAGNOSTIC MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 94. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TISSUE DIAGNOSTIC MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL TISSUE DIAGNOSTIC MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CANADA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CANADA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CANADA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CANADA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CALIFORNIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CALIFORNIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. CALIFORNIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. CALIFORNIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. FLORIDA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. FLORIDA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. FLORIDA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. FLORIDA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ILLINOIS TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ILLINOIS TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ILLINOIS TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ILLINOIS TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. NEW YORK TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. NEW YORK TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. NEW YORK TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. NEW YORK TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. OHIO TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. OHIO TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. OHIO TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. OHIO TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. PENNSYLVANIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. PENNSYLVANIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. PENNSYLVANIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. PENNSYLVANIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. TEXAS TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. TEXAS TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. TEXAS TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. TEXAS TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. CHINA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. CHINA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. CHINA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. CHINA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. INDIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. INDIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. INDIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. INDIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. ITALY TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. ITALY TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. ITALY TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. ITALY TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. QATAR TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. QATAR TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. QATAR TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. QATAR TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. GLOBAL TISSUE DIAGNOSTIC MARKET: SCORES
  • TABLE 163. GLOBAL TISSUE DIAGNOSTIC MARKET: BUSINESS STRATEGY
  • TABLE 164. GLOBAL TISSUE DIAGNOSTIC MARKET: PRODUCT SATISFACTION
  • TABLE 165. GLOBAL TISSUE DIAGNOSTIC MARKET: RANKING
  • TABLE 166. GLOBAL TISSUE DIAGNOSTIC MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 167. GLOBAL TISSUE DIAGNOSTIC MARKET: SHARE, BY COMPANY, 2020
  • TABLE 168. GLOBAL TISSUE DIAGNOSTIC MARKET: MERGER & ACQUISITION
  • TABLE 169. GLOBAL TISSUE DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 170. GLOBAL TISSUE DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 171. GLOBAL TISSUE DIAGNOSTIC MARKET: INVESTMENT & FUNDING
  • TABLE 172. GLOBAL TISSUE DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 173. GLOBAL TISSUE DIAGNOSTIC MARKET: LICENSE & PRICING
  • TABLE 174. GLOBAL TISSUE DIAGNOSTIC MARKET: CONTACT DETAILS